Inflammatory factor tumor necrosis factor-α (TNF-α) activates P-glycoprotein (P-gp) by phosphorylating c-Jun and thus promotes transportation in placental cells
Huaying Li1, Li Yan2, Biao Li1
1Department of Neonatology, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Insights
Tumor necrosis factor-alpha (TNF-α) activates P-glycoprotein (P-gp) by upregulating c-Jun, enhancing placental drug transport. This modulation of the placental barrier is crucial for protecting the fetus from harmful substances.
Area of Science:
- Pharmacology
- Cell Biology
- Biochemistry
Background:
- P-glycoprotein (P-gp), encoded by the ABCB1 gene, is a key fetal protector in the placenta, actively transporting xenobiotics back to maternal circulation.
- The influence of tumor necrosis factor-alpha (TNF-α) on P-gp function and placental molecule transport was previously unknown.
Purpose of the Study:
- To investigate the role of TNF-α in placental molecule-transporting activity.
- To elucidate the underlying molecular mechanisms by which TNF-α affects placental transport.
Main Methods:
- Utilized human placental cell lines (Bewo, JEG-3, JAR) treated with recombinant TNF-α (rTNF-α).
- Assessed c-Jun expression and binding to the ABCB1 promoter using Western blot, ChIP, and EMSA.
- Quantified P-gp substrate uptake and digoxin efflux, and measured c-Jun phosphorylation.
Main Results:
- rTNF-α dose-dependently upregulated c-Jun expression and its binding to the ABCB1 promoter.
- TNF-α increased the transport activity of P-gp, evidenced by altered uptake of P-gp substrates and digoxin efflux.
- rTNF-α was found to regulate P-gp activity by promoting c-Jun phosphorylation.
Conclusions:
- TNF-α activates P-gp-mediated placental molecule transport through direct upregulation and phosphorylation of c-Jun.
- These findings highlight TNF-α's clinical significance in modulating the placental barrier for fetal protection against drugs.
Background:
P-glycoprotein (P-gp), encoded by the ABCB1 gene, actively pumps drugs and other xenobiotics from trophoblast cells back into the maternal circulation and thus acts as one of the most critical protectors of the fetus. The effect of tumor necrosis factor-α (TNF-α) on P-gp and molecule-transporting activity remains unknown. The goal of this study was to investigate the role of TNF-α in placental molecule-transporting activity and the underlies mechanisms.
Methods:
Cultured human placental choriocarcinoma cell lines, Bewo, JEG-3 and JAR, were used in this study. Cultured cells were incubated with 5, 10 and 20 ng/mL of recombinant TNF-α (rTNF-α) for 24 h, respectively, for follow-up experiments. The dimer form and expression of activator protein-1 (AP-1) family members were detected using Western blot (WB) and chromatin immunoprecipitation (ChIP). mRNA and protein expression of ABCB1 were detected using reverse transcriptional quantitative polymerase chain reaction (RT-qPCR) and WB, respectively. Double luciferase labeling was used to verify the concentration of digoxin. Electromobility shift assay (EMSA) and ChIP were used to identify the binding ability of c-Jun to ABCB1 gene promoter. Proliferation and apoptosis of Bewo cells were determined using flow cytometry. Digoxin concentration were determined using dual luciferase labeling method.
Results:
Administration of rTNF-α upregulated the expression of c-Jun but not JunB or JunD in a dose-dependent manner and promoted the binding of c-Jun to the ABCB1 promoter region in Bewo cells. rTNF-α also increased the uptake of two P-gp-specific substrates, Rh123 and DiOC2(3), a function reversed by the addition of SP600125 and SR11302. We also found that rTNF-α increased the efflux ratio of digoxin, an outcome that was reversed, as expected, by inhibiting c-Jun and P-gp binding activities. Furthermore, we identified that rTNF-α tightly regulates the molecule-transporting activity of P-gp by promoting the phosphorylation of c-Jun.
Conclusions:
TNF-α activates P-gp to promote placental molecule-transporting activity by directly upregulating c-Jun expression and phosphorylation. These findings demonstrate the clinical significance of TNF-α in modulating the placental barrier, which plays an important role in protecting fetus against harmful drugs.
More Related Videos
Related Concept Videos
Enzyme-linked Receptors
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
TGF - β Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...


